Innopeutics Corporation

Innopeutics is a biotech company established with the mission to combat human diseases through innovative therapeutic development. Our primary objective is to revolutionize the drug development process through advanced knowledge and a collaborative R&D culture, ultimately bringing happiness and hope to patients and their families. Drawing upon several years of dedicated work on our proprietary AAV (Adeno-associated virus) manufacturing platform, Innopeutics is actively advancing therapies for neurodegenerative diseases, autoimmune disorders, and cancer. Our leading pipeline includes the IPS-101/102 programs, targeting Parkinson's and Alzheimer's diseases, with the first-in-human study scheduled for 2025. At Innopeutics, our core values are centered around the well-being of patients and their families. We are committed to ceaseless R&D efforts for their benefit, and we aspire to help patients and their families create cherished memories through our innovative therapies.